{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:45:40Z","timestamp":1775065540517,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jogc.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T14:30:04Z","timestamp":1628692204000},"page":"1416-1425.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-1641","authenticated-orcid":false,"given":"Olga","family":"Gajic-Veljanoski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis K.","family":"Schaink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanette","family":"Okun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbra","family":"de Vrijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Pechlivanoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Sikich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2021.07.014_bib0001","unstructured":"MedlinePlus. Rh incompatibility. Available at: https:\/\/medlineplus.gov\/ency\/article\/001600.htm. Accessed on October 19, 2020."},{"key":"10.1016\/j.jogc.2021.07.014_bib0002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1423-0410.2004.00569.x","article-title":"Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn","volume":"87","author":"Daniels","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.jogc.2021.07.014_bib0003","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1701-2163(16)30995-1","article-title":"Prevention of Rh alloimmunization","volume":"25","author":"Fung Kee Fung","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.07.014_bib0004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jogc.2016.12.006","article-title":"No. 343-routine non-invasive prenatal prediction of fetal RhD genotype in Canada: the time is here","volume":"39","author":"Johnson","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.07.014_bib0005","first-page":"1","article-title":"Noninvasive fetal RhD blood group genotyping: a health technology assessment","volume":"20","year":"2020","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.jogc.2021.07.014_bib0006","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOH.0000000000000379","article-title":"Genotyping to prevent Rh disease: has the time come?","volume":"24","author":"van der Schoot","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jogc.2021.07.014_bib0007","series-title":"Systematic reviews of economic evaluations. In Systematic reviews: CRD's guidance for undertaking reviews in health care","year":"2009"},{"key":"10.1016\/j.jogc.2021.07.014_bib0008","series-title":"Cochrane handbook for systematic reviews of interventions, version 5.1.0","article-title":"Incorporating economics evidence","author":"Shemilt","year":"2011"},{"key":"10.1016\/j.jogc.2021.07.014_bib0009","unstructured":"Higgins JPTG, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. Available at: www.handbook.cochrane.org. Accessed on July 2, 2021."},{"key":"10.1016\/j.jogc.2021.07.014_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","article-title":"GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-an overview in the context of health decision-making","volume":"129","author":"Brozek","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jogc.2021.07.014_bib0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005650-200301000-00007","article-title":"Development and validation of a grading system for the quality of cost-effectiveness studies","volume":"41","author":"Chiou","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.jogc.2021.07.014_bib0012","first-page":"53","article-title":"Examining the value and quality of health economic analyses: implications of utilizing the QHES","volume":"9","author":"Ofman","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jogc.2021.07.014_bib0013","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.jogc.2021.07.014_bib0014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ","volume":"313","author":"Drummond","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2021.07.014_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2004.04.020","article-title":"The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal","volume":"127","author":"Spiegel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jogc.2021.07.014_bib0016","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hec.1486","article-title":"Systematic reviews of economic evaluations: utility or futility?","volume":"19","author":"Anderson","year":"2010","journal-title":"Health Econ"},{"key":"10.1016\/j.jogc.2021.07.014_bib0017","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/1471-0528.15152","article-title":"High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis","volume":"125","author":"Saramago","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2021.07.014_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19140","article-title":"Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold","volume":"19","author":"Claxton","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jogc.2021.07.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/pd.5415","article-title":"Cell free fetal DNA to triage antenatal rhesus immune globulin: is it really cost-effective in the United States?","author":"Moise","year":"2019","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.jogc.2021.07.014_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/AOG.0b013e31829f8814","article-title":"Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis","volume":"122","author":"Hawk","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.07.014_bib0021","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/pd.5176","article-title":"Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: a cost-effectiveness analysis","volume":"37","author":"Gordon","year":"2017","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.jogc.2021.07.014_bib0022","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/1471-0528.13801","article-title":"Cost-effectiveness of first trimester non-invasive fetal RhD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis","volume":"123","author":"Neovius","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2021.07.014_bib0023","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1701-2163(15)30864-1","article-title":"Cost-effectiveness of the management of Rh-negative pregnant women","volume":"35","author":"Duplantie","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.07.014_bib0024","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.14723","article-title":"Costs and benefits of non-invasive fetal RhD determination","volume":"45","author":"Teitelbaum","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.07.014_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12884-018-2114-5","article-title":"Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women","volume":"18","author":"Darlington","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"issue":"13","key":"10.1016\/j.jogc.2021.07.014_bib0026","doi-asserted-by":"crossref","DOI":"10.3310\/hta22130","article-title":"High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation","volume":"22","author":"Saramago","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jogc.2021.07.014_bib0027","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S2352-4642(18)30071-3","article-title":"Rhesus disease: a global prevention strategy","volume":"2","author":"Zipursky","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jogc.2021.07.014_bib0028","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/01443610701469941","article-title":"The safety of RhIG in the prevention of haemolytic disease of the newborn","volume":"27","author":"Hirose","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2021.07.014_bib0029","first-page":"17","article-title":"The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland","volume":"93","author":"Craig","year":"2000","journal-title":"Ir Med J"},{"key":"10.1016\/j.jogc.2021.07.014_bib0030","doi-asserted-by":"crossref","DOI":"10.3310\/hta7040","article-title":"A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative","volume":"7","author":"Chilcott","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jogc.2021.07.014_bib0031","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1471-0528.2004.00226.x","article-title":"The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative","volume":"111","author":"Chilcott","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2021.07.014_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13100","article-title":"Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation","volume":"13","author":"Pilgrim","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jogc.2021.07.014_bib0033","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study","volume":"336","author":"Finning","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2021.07.014_bib0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2393-11-5","article-title":"A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales","volume":"11","author":"Szczepura","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2021.07.014_bib0035","doi-asserted-by":"crossref","first-page":"i5789","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"de Haas","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2021.07.014_bib0036","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1701-2163(16)35239-2","article-title":"Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?","volume":"34","author":"Koby","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.07.014_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216321006009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216321006009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:39:23Z","timestamp":1761665963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216321006009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1701216321006009"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2021.07.014","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}